Transmucosal Permeation of Topically Applied Diclofenac and Piroxicam

Journal of Applied Research

Volumn 3, Issue 4, 2003, Pages 505-511

  Van Der Bijl, Pieter ^a   Van Eyk, Armorel D ^a   Seifart, Heiner I ^a   Viljoen, Ianda ^a   Jooste, Marli ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

Diclofenac; Human mucosa; Permeability studies; Piroxicam

Indexed keywords

DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

ADULT; AGED; ANALYSIS OF VARIANCE; AQUEOUS SOLUTION; ARTICLE; BONE INJURY; CHEEK MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG PENETRATION; FEMALE; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MUCOSA; MYALGIA; OSTEOARTHRITIS; PARTITION COEFFICIENT; POSTMENOPAUSE; POSTOPERATIVE PAIN; RHEUMATOID ARTHRITIS; STEADY STATE; VAGINA MUCOSA; VAGINAL HYSTERECTOMY;

EID: 2342607963     PISSN: 1537064X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Stiel D: Exploring the link between gastrointestinal complications and over-the-counter analgesics: current issues and considerations. Am J Therapeutics 7:91-98, 2000.
2. Heyneman CA, Lawless-Liday C, Wall GC: Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs 60:555-574, 2000.
3. Singh G: Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information System. Am. J Therapeutics 7:115-121, 2000.
4. Gabriel SE, Jaakkimainen L, Bombardier C: Risk for serious gastrointestinal complications related to the use of nonsteroidal anti-inflammatory drugs. Ann Intern Med 115:787-796, 1991.
5. Laporte J-R, Carne X, Vidal X, et al: Upper gastrointestinal bleeding in relation to previous use of analgesics and nonsteroidal anti-inflammatory drugs. Lancet 337:85-89, 1991.
6. Kaufman DW, Kelly JP, Sheehan JE, et al: Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 53:485-494, 1993.
7. Rodriguez LAG, Jick H: Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 343:769-772, 1994.
8. Urban MK: Cox-2 specific inhibitors offer improved advantages over traditional NSAIDs. Orthopedics 23:S761-S764, 2000.
9. Vaile JH, Davis P: Topical NSAIDs for musculoskeletal conditions. Drugs 56:783-799, 1998.
10. Yalcin S, Altundag K, Asil M, et al: Sublingual piroxicam for cancer pain. Med Oncol 15:137-139, 1998.
11. Maamer M, Aurousseau M, Colau JC: Concentration of benzydamine in vaginal mucosa following local application: an experimental and clinical study. Int J Tissue Reac 9:135-145, 1987.
12. Sironi M, Milanese C, Vecchi A: Benzydamine inhibits the release of tumor necrosis factor-alpha and monocyte chemotactic protein-1 by Candida albicans-stimulated human peripheral blood cells. Int J Clin Res 27:118-122, 1997.
13. Passali D, Volonte M, Passali GC, et al: Efficacy and safety of ketoprofen lysine salt mouth wash versus benzydamine hydrochloride mouthwash in acute pharyngeal inflammation: a randomized, single-blind study. Clin Ther 23:1508-1518, 2001.
14. Cecchini G, Ferutta P, Solda A, et al: Vaginiti aspecifiche e trattamento topico. Confronto tra flunoxaprofene e benzidamina [Non-specific vaginitis and topical treatment. Comparison of flunoxaprofen and benzydamine]. Minerva-Ginecol 41:287-290, 1989.
15. Saxen MA, Ambrosius WR. Rehemtula al-KF, et al: Sustained relief of oral aphthous ulcer pain from topical diclofenac in hyaluronan: a randomized, double-blind clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84:356-361, 1997.
16. Van der Bijl P, Thompson IOC, Squier CA: Comparative permeability of human vaginal and buccal mucosa to water. Eur. J Oral Sci 105:571-575, 1997.
17. Van der Bijl P, Van Eyk AD, Thompson IOC: Permeation of 17β-estradiol through human vaginal and buccal mucosa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:393-398, 1998.
18. Van der Bijl P, Van Eyk AD, Thompson IOC: Penetration of human vaginal and buccal mucosa by 4.4 and 12 kDa FITC-labeled dextrans. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:686-691, 1998.
19. Van der Bijl P, Van Eyk AD. Thompson IOC: Diffusion rates of vasopressin through human vaginal and buccal mucosa. Eur J Oral Sci 106:958-962, 1998.
20. Van der Bijl P, Penkler L, Van Eyk AD: Permeation of sumatriptan through human vaginal and buccal mucosa. Headache 40:137-141, 2000.
21. Van der Bijl P, Van Eyk AD: Penetration of benzo[a]pyrene through human buccal and vaginal mucosa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87:452-455, 1999.
22. Van der Bijl P, Van Eyk AD, Thompson IOC: Effect of freezing on the permeability of human buccal and vaginal mucosa. S Afr J Sci 94:499-502, 1998.
23. Higuchi WI: Analysis of data on the medicament release from ointments. J Pharm Sci 51:802-804, 1962.
24. Guy RH, Hadgraft J: On the determination of drug release rates from topical dosage forms. Int J Pharm 60:R1-R3, 1990.
25. Rahman MS, Babar A, Patel NK, et al: Medicament release from ointment bases. V. Naproxen in vitro release and in vivo percutaneous absorption in rabbits. Drug Dev Ind Pharm 16:651-672, 1990.
26. Squier CA: The permeability of oral mucosa. Crit Rev Oral Biol Med 2:13-32, 1991.
27. Budavari S, O'Neil MJO, Smith A, et al (Eds.): The Merck Index. Whitehouse Station, NJ: Merck Research Laboratories; 1996:3133, 7657.
28. Thompson IOC, Van der Bijl P, Van Wyk CW, et al: A comparative light-microscopic, electron-microscopic and chemical study of human vaginal and buccal epithelium. Arch Oral Biol 46:1091-1098, 2001.
29. Ho HO, Huang FC, Sokoloski TD, et al: The influence of cosolvents on the in vitro percutaneous penetration of Diclofenac sodium from a gel system. J Pharm Pharmacol 46:636-642, 1994.